<DOC>
	<DOCNO>NCT01221935</DOCNO>
	<brief_summary>The goal observational study learn Pristiq currently use general practice psychiatrist primary care physician currently perceive Pristiq term efficacy , tolerability , adherence compare treatment major depressive disorder ( MDD ) .</brief_summary>
	<brief_title>Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release ( Pristiq ) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder</brief_title>
	<detailed_description>It retrospective patient chart study among psychiatrist primary care physician ( PCPs ) treat patient suffer major depressive disorder ( MDD ) . Physicians ask general medical question order quantify prescribe behavior perception treatment performance . A retrospective patient chart review perform patient data collect document patient characteristic actual treatment outcome . Upon qualification , specific instruction chart review provide . Once identify chart pull , physician instruct continue on-line survey . In total , approximately 450 psychiatrist 450 primary care physician participate trial .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<mesh_term>Serotonin Noradrenaline Reuptake Inhibitors</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Patients must adult , diagnosed major depressive disorder treat pharmacotherapy . Physicians must either psychiatrist primary care physician , prescriber Pristiq , least 3 chart represent 4 identified patient type , clinical practice 4 35 year , primarily office base ( 50 % + ) , participate research study relate antidepressant antidepressant therapy within past month , consultant professional relationship pharmaceutical company clinical trial speak engagement , employ affiliate advertising agency , market research company , pharmaceutical company . Patients treated depression .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>retrospective chart review study</keyword>
	<keyword>desvenlafaxine utilization</keyword>
	<keyword>psychiatrist primary care physician</keyword>
	<keyword>treatment major depressive disorder</keyword>
</DOC>